792
Participants
Start Date
September 20, 2016
Primary Completion Date
March 2, 2021
Study Completion Date
December 7, 2023
Dolutegravir
Standard of Care
PI or non nucleoside transcriptase inhibitors
Universitata Frankfurt, Frankfurt
UkE Eppendorf Hamburg, Hamburg
Centro Materno-Infantil de Norte, Porto
King Edward VIII Hospital, Durban
Africa Health Research Institute (AHRI), Hlabisa
PHRU Klerksdorp, Klerksdorp
Kid-Cru, Parow
PHRU, Soweto
Hospital San Joan de Defu, Barcelona
Hospital 12 de Octubre, Madrid
Hospital La Paz, Madrid
Prapokklao Hospital, Chanthaburi
Nakornping Hospital, Chiang Mai
Chiangrai Prachanukroh Hospital, Chiang Rai
Khon Kaen Hospital, Khon Kaen
Mahasarakam Hospital, Maha Sarakham
Phayao Hospital, Phayao
Baylor, Kampala
JCRC, Kampala
MUJHU, Kampala
JCRC, Mbarara
Birmingham Heartlands Hospital, Birmingham
Leeds General Infirmary, Leeds
Leicester Royal Infirmary, Leicester
Great Ormand Street Hospital, London
Kings College Hospital, London
St Mary's Hospital, London
UZCRC, Harare
Collaborators (1)
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Program for HIV Prevention and Treatment (PHPT)
UNKNOWN
ViiV Healthcare
INDUSTRY
MRC CTU at UCL
UNKNOWN
PENTA Foundation
NETWORK